“Predictive role of CCND1, FGFR1 gene amplifications and PIK3CA mutations for endocrine therapy of primary metastatic breast cancer ” (2021) Voprosy onkologii, 67(5), pp. 646–657. doi:10.37469/0507-3758-2021-67-5-646-657.